Corcept Therapeutics Inc financial data

Symbol
CORT on Nasdaq
Industry
Pharmaceutical Preparations
Location
101 Redwood Shores Parkway, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 464 % -10.4%
Quick Ratio 7.31 % -0.68%
Debt-to-equity 21.3 % +0.43%
Return On Equity 24.8 % +29.8%
Return On Assets 20.4 % +29.7%
Operating Margin 22.8 % +4.63%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 105M shares +1.64%
Common Stock, Shares, Outstanding 103M shares -4.11%
Entity Public Float 1.83B USD -11.2%
Common Stock, Value, Issued 135K USD +1.5%
Weighted Average Number of Shares Outstanding, Basic 103M shares +1.33%
Weighted Average Number of Shares Outstanding, Diluted 114M shares +2.36%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 629M USD +39.7%
Research and Development Expense 231M USD +39%
Costs and Expenses 485M USD +37.9%
Operating Income (Loss) 143M USD +46.1%
Nonoperating Income (Expense) 23M USD +65.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 166M USD +48.5%
Income Tax Expense (Benefit) 24.5M USD +18.8%
Net Income (Loss) Attributable to Parent 142M USD +55.2%
Earnings Per Share, Basic 1.35 USD/shares +53.4%
Earnings Per Share, Diluted 1.25 USD/shares +56.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 137M USD +22.8%
Marketable Securities, Current 243M USD -0.16%
Accounts Receivable, after Allowance for Credit Loss, Current 59.7M USD +72.5%
Inventory, Net 8.05M USD +7.15%
Other Assets, Current 4.58M USD
Assets, Current 467M USD +8.22%
Deferred Income Tax Assets, Net 127M USD +45.6%
Property, Plant and Equipment, Net 2.93M USD +870%
Operating Lease, Right-of-Use Asset 5.5M USD +2992%
Other Assets, Noncurrent 6.97M USD +6.62%
Assets 784M USD +32%
Accounts Payable, Current 18.6M USD +11.2%
Employee-related Liabilities, Current 25.5M USD +64.1%
Accrued Liabilities, Current 79.5M USD +14.1%
Liabilities, Current 126M USD +3.56%
Accrued Income Taxes, Noncurrent 12.8M USD +22.7%
Operating Lease, Liability, Noncurrent 6.36M USD
Liabilities 145M USD +9.88%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.57M USD
Retained Earnings (Accumulated Deficit) 513M USD +38.2%
Stockholders' Equity Attributable to Parent 639M USD +38.4%
Liabilities and Equity 784M USD +32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 23.8M USD -8.48%
Net Cash Provided by (Used in) Financing Activities -543K USD -400%
Net Cash Provided by (Used in) Investing Activities -9.01M USD -104%
Common Stock, Shares Authorized 280M shares 0%
Common Stock, Shares, Issued 134M shares +2.59%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.2M USD -93.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 137M USD +22.8%
Deferred Tax Assets, Valuation Allowance 15.9M USD +7.47%
Deferred Tax Assets, Gross 107M USD +39.2%
Operating Lease, Liability 6.79M USD +2918%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 144M USD +53.6%
Lessee, Operating Lease, Liability, to be Paid 8.73M USD +3664%
Property, Plant and Equipment, Gross 4.48M USD +6.85%
Operating Lease, Liability, Current 432K USD +92%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.55M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.38M USD +792%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +12.5%
Deferred Income Tax Expense (Benefit) -7.16M USD -6.48%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.94M USD +27629%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.6M USD
Deferred Tax Assets, Operating Loss Carryforwards 3.94M USD -19.3%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 13M USD +14%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.65M USD
Operating Lease, Payments 1.98M USD -16%
Additional Paid in Capital 739M USD +11.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 52K USD -56.3%
Depreciation, Depletion and Amortization 68K USD -60.5%
Deferred Tax Assets, Net of Valuation Allowance 90.6M USD +47.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%